大麻素 (CBD) 和结肠直肠瘤发生:通过血清增强通路的潜在双重调节作用
Zhenhua Liu1,2
1Nutrition and Cancer Prevention Laboratory, School of Public Health & Health Sciences, University of Massachusetts, Amherst, MA 01003, USA.
Current oncology (Toronto, Ont.)
|July 25, 2025
概括
大麻素 (CBD) 通过影响细胞生长和炎症,显示出对结直肠癌的潜力. 然而,需要更多的研究来确认其益处,并了解与CBD相关的风险.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 2018年农业法案将大麻衍生的大麻二醇 (CBD) 合法化,增加了对其健康益处的兴趣.
- 虽然CBD市场迅速扩大,但科学研究和临床证据却落后,许多健康主张没有证据支持.
- 临床前研究表明,CBD可能通过影响细胞增殖,细胞亡和炎症,在结直肠癌 (CRC) 中具有抗瘤作用.
研究的目的:
- 批判性地审查关于CBD在结直肠瘤发生中的作用的现有证据.
- 检查CBD的分子机制,特别是其与CRC中血清激素系统的相互作用.
- 评估CBD在临床环境中对CRC的治疗潜力和风险.
主要方法:
- 关于CBD和结直肠癌的临床前和临床研究的文献综述.
- 分析分子通路,包括细胞增殖,细胞亡,炎症和血清系统.
- 检查CBD的双重抗瘤和促瘤性质.
主要成果:
- 目前,有限的临床证据支持CBD在结直肠癌中所谓的抗瘤作用.
- 在CRC发育过程中,CBD与血清系统的相互作用呈现出一种复杂的机制,具有潜在的双重效应 (保护性和有害性).
- 对于CBD在结肠直肠瘤发生中的确切作用仍未完全阐明.
结论:
- 进一步的研究对于了解CBD在结直肠瘤发生中的复杂机制至关重要.
- 需要进行临床试验来评估CBD的治疗潜力和结直肠癌的安全性.
- 阐明CBD与血清能系统相互作用可能会导致预防和治疗CRC的新策略,优化疗效和降低风险.
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
368
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
368
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
405
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
405
01:19Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:54Canonical Wnt Signaling Pathway
8.9K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K